Despite the lack of evidence of the safety of antipsychotics in children, who are smaller in size and still rapidly developing, the number of prescriptions to English youth has doubled between 2000 to 2019, a study suggests.
The researchers from the University of Manchester examined over seven million children and adolescents aged three to 18.
